GooglePills_Proposal_Skin_Cancer (Gemini 3.0 + PhytoIntelligence 1.9)

Background: Conventional pharmacotherapy for metastatic melanoma and advanced squamous cell carcinoma faces significant challenges, primarily driven by acquired resistance to BRAF/MEK inhibitors and immune checkpoint blockade failure. The PhytoIntelligence 1.9 (PI 1.9) algorithm leverages computational docking and systems biology to identify synergistic phytochemical complexes capable of multi-nodal signaling inhibition. Objective: This protocol delineates the theoretical framework and experimental validation of "Dermo-Phyt 4X," a combinatorial formulation targeting the MAPK/ERK, PI3K/AKT/mTOR, and JAK/STAT pathways simultaneously. Projected Outcomes: We hypothesize that the PI 1.9 derived formulation will demonstrate aCombination Index (CI) < 0.8 (indicating strong synergy) in A375 and SK-MEL-28 cell lines, restoring apoptotic sensitivity in chemoresistant phenotypes via the downregulation of Bcl-2 and suppression of NF-κB nuclear translocation. This protocol provides the standard operating procedures for in vitro validation and statistical power analysis for subsequent in vivo translation.